Company Filing History:
14 out of 164 
1 out of 832,843 Years Active: 1996-2004
Title: The Innovations of Rosemay Vazeux: A Pioneer in Intercellular Adhesion Molecules
Introduction
Rosemay Vazeux is an innovative inventor based in Seattle, WA, who has made significant contributions to the field of molecular biology. With an impressive portfolio of 15 patents, her work focuses on the development and understanding of intercellular adhesion molecules, which play critical roles in various biological processes.
Latest Patents
Among her latest patents, Vazeux has developed DNA sequences that encode a novel human intercellular adhesion molecule polypeptide, designated as "ICAM-R." This innovation includes not only the polypeptide itself but also its variants, highlighting its potential applications in medical and research fields. Moreover, she has disclosed methods and materials for the recombinant production of ICAM-R, along with antibodies that are specific to this molecule. These antibodies are essential for isolating ICAM-R from natural sources and for modulating ligand/receptor binding reactions, thus contributing to advancements in therapeutic strategies.
Career Highlights
Throughout her career, Rosemay Vazeux has collaborated with various reputable organizations, one notable company being Icos Corporation. Her work has been instrumental in driving research and application in the biopharmaceutical industry, making her a prominent figure among patent holders in this niche.
Collaborations
Vazeux has worked alongside renowned colleagues, including W. Michael Gallatin, with whom she has shared insights and innovations in their respective research endeavors. Such collaborations have fostered an environment of creative scientific inquiry and development, propelling their projects to new heights.
Conclusion
In conclusion, Rosemay Vazeux's contributions to the field of intercellular adhesion molecules through her numerous patents exemplify her innovative spirit and dedication to advancing medical science. Her work, combined with fruitful collaborations, positions her as a key player in the landscape of modern biotechnology, with the potential for significant impacts on future therapeutic approaches.